intellectual property

COVID-19 Vaccine Supply Chain and Regulatory Transparency Technical Symposium

Zoom/YouTube – 10:00 – 13.00, 15.00-18:00 (CET)


10:00 – 10:15

SESSION 1: Opening



10:15 – 11:30

SESSION 2: Mapping vaccine manufacturing and trade


Summary Report

  • What are the latest projections on COVID-19 vaccine manufacturing output?
  • What can supply chain mapping exercises tell us about vaccine manufacturing production and related value chains?
  • Vaccine producers are experiencing bottlenecks in their supply chains. Which types of problems are being experienced and what can policy makers do to address them?

MODERATOR:  Robert Koopman, Chief Economist, World Trade Organization

11:30 – 13:00

SESSION 3: Mapping cross-border movement of vaccine inputs


Summary Report

  • What are the vaccines inputs that matter and how are they traded across borders?
  • Are trade measures creating bottlenecks in input supply chains, and if so, where and why?
  • What approaches can Members and other stakeholders take to facilitate the efficient cross-border movement of vaccine inputs?
  • What could be done to improve the monitoring and facilitate these cross-border movements?

MODERATOR: Suja Rishikesh Mavroidis, Director, Market Access Division, WTO

15:00 – 16:30

SESSION 4: Promoting transparency and convergence in the regulatory landscape


Summary Report

  • What approaches are being used to expedite the regulatory processes needed to get new manufacturing capacity up and running? 
  • How can we cooperate internationally to quickly and safely manufacture, approve and disseminate needed vaccines, therapeutics and diagnostics?
  • How can transparency in the regulatory approval process be strengthened?
  • How do we increase regulatory cooperation and capacity building for better future pandemic preparedness?

MODERATOR: Aik Hoe Lim, Director, Trade and Environment Division, WTO

16:30 – 17:45

SESSION 5:  Beyond vaccines: mapping other COVID-19 essential health technologies and trade


Summary Report

  • How can value chain mapping techniques be used to chart trade in other COVID-19 essential health technologies?
  • What manufacturing, input and regulatory bottlenecks are these COVID-19 essential health technologies facing and why?

MODERATOR: Antony Taubman, Director, Intellectual Property, Government Procurement and Competition Division, WTO

17:45 – 18:00

SESSION 6: Closing




Problems viewing this page? If so, please contact [email protected] giving details of the operating system and web browser you are using.